terlipressin
英
美
网络 特利加压素; 加压素; 特利升压素; 血管加压素; 三甘氨酰赖氨酸加压素
双语例句
- Protective strategy of Terlipressin on the remnant livers after major hepatectomy in rats residual expansion of tank volume
特利加压素对肝大部切除术后大鼠小体积残肝的保护性治疗罐体容积残余变形值 - Objective To evaluate the clinical efficacy of Terlipressin for treatment of intractable septic shock.
目的旨在探讨特利加压素（Terlipressin）对脓毒血症难治性休克的临床应用价值。 - Conclusion Terlipressin have clinical therapeutic effects for intractable septic shock.
结论对严重脓毒血症难治性休克，特利加压素具有一定的临床应用价值。 - Conclusions Perioperative terlipressin-based comprehensive treatment can effectively improve renal function to promote survival rate in patients with HRS.
结论对肝移植围手术期的HRS病人采用terlipressin结合CRRT及2剂赛尼哌诱导疗法的综合治疗可以明显改善病人的肾功能，提高生存率。 - Conclusion: Terlipressin improved the clinical syndromes and prognosis of patients with hepatorenal syndrome ( HRS), reduced the level of blood creatinine, increased the urine volume. Terlipressin will provid us a new way to treat patients with hepatorenal syndrome ( HRS).
结论：特利加压素治疗肝肾综合征可改善患者临床症状及预后，降低血肌酐水平，增加尿量，为治疗该病提供新的措施。 - Effect observe of terlipressin on hepatorenal syndrome
特利加压素治疗肝肾综合征的疗效观察 - Results 6h after the administer of Terlipressin, patients 'MAP rose and shock index number reduced dramatically, 12h after treatment by Terlipressin, patients' HR improved significantly ( P0.01).
结果特利加压素使用6h后平均动脉压明显上升、休克指数明显下降，使用12h后心率、尿量明显改善。 - Effects of terlipressin and pituitrin on portal hemodynamics in rabbits with prehepatic portal hypertension
特利加压素、垂体后叶素对正常及门脉高压兔门脉血流动力学影响的研究